Posts

Trump signs executive order to overhaul pediatric vaccine recommendations

President Donald Trump on Monday signed an Executive Order recognizing revised "Gold Standard" childhood vaccine recommendations for U.S. children, reducing routine shots from 18 to 11 core diseases and separating the combined MMR vaccine into three single‑disease shots delivered at separate visits. The order reclassifies many vaccines – including hepatitis A, hepatitis B, meningococcal disease, influenza, rotavirus and COVID‑19 – into categories for high‑risk groups or shared clinical decision‑making with parents and providers, rather than recommending them for all children. The new guidance urges states to align school requirement laws with the federal recommendations and directs federal agencies to study safety and schedule changes, while public health agencies and pediatric groups warn that the plan contradicts established science and could lower immunization rates. Sources: Delivering Gold Standard Childhood Vaccine Recommendations for ... Trump redoubles effor...

AbCellera, Silence Therapeutics, and InduPro Raise Significant Funding

Boulevard Bio launches with $65M to target IgAN and other autoimmune diseases with quarterly‑dosed BAFF/APRIL bispecific against Vera's Trutakna

Definium's LSD-based drug clears bar in first Phase 3 anxiety disorder trial

Eli Lilly Takes First Legal Action Against Black Market for Experimental Obesity Drug Retatrutide

Vaccine Makers and Experts Reject Trump’s Push to Split MMR Shot

BridgeBio Posted Q2 Revenue Beat, but Faces Higher Near‑Term Launch Opex, Morgan Stanley Says – Key Highlights

Cullinan and Taiho Report Phase III Win for Zipalertinib–Chemotherapy Combo in First-Line EGFR Exon 20 Insertion–Mutant NSCLC

Google’s new wearable health features track insulin resistance trends on Pixel Watch and Fitbit Air

Trump Issues Executive Order Overhauling Pediatric Vaccine Recommendations

Eli Lilly sues six companies over alleged illegal sales of retatrutide knockoffs

Definium Hits Another Phase 3 Homerun with Psychedelic Sea Change for Anxiety

Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset alvelestat for AATD-LD